Clinical development update: 1st dengue vaccine candidate
Main Author: | Alain Bouckenooghe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-02-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087615001142 |
Similar Items
-
Recent Developments in Recombinant Protein–Based Dengue Vaccines
by: Nagesh K. Tripathi, et al.
Published: (2018-08-01) -
Immunogenicity of the CYD tetravalent dengue vaccine using an accelerated schedule: randomised phase II study in US adults
by: Judith Kirstein, et al.
Published: (2018-09-01) -
Efficacy of tetravalent dengue vaccine: A systematic review and meta-analysis
by: Ashish Wasudeo Khobragade, et al.
Published: (2021-01-01) -
Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands
by: Guy El Helou, et al.
Published: (2020-06-01) -
A new tetravalent Dengue vaccine formulation based on four chimeric envelope domain III-capsid proteins induces a functional immune response in mice and non-human primates
by: Edith Suzarte, et al.